At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CRC California Resources
Closed 09-01 16:00:00 EDT
53.88
+0.85
+1.60%
盘后53.98
+0.10+0.19%
19:54 EDT
High53.93Low53.15Vol709.37K
Open53.79D1 Closing53.03Amplitude1.48%
Mkt Cap4.77BTradable Cap4.50BTotal Shares88.60M
T/O38.15MT/O Rate0.85%Tradable Shares83.56M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

California Resources Outlines Potential CO2 Pipeline Network to Link California Emitters with TerraVault Storage Sites
Reuters  ·  05:43
California Resources Outlines Potential CO2 Pipeline Network to Link California Emitters with TerraVault Storage Sites
California Resources Sees 3Q Crimson G&A, Capex at $1-$2 Million Each
Reuters  ·  04:30
California Resources Sees 3Q Crimson G&A, Capex at $1-$2 Million Each
California Resources Corporation Completes Acquisition of Crimson
THOMSON REUTERS  ·  04:30
California Resources Corporation Completes Acquisition of Crimson
Elevance update guidelines cover Freenome CRC test, says Guggenheim
TIPRANKS  ·  09-01 23:55
Elevance update guidelines cover Freenome CRC test, says Guggenheim
California Resources Releases 2025 Sustainability Report Update
Reuters  ·  08-31 23:31
California Resources Releases 2025 Sustainability Report Update
Oil Stocks Retail Investors Are Watching For Direct Crude Price Exposure
Simply Wall St.  ·  08-31 14:14
Oil Stocks Retail Investors Are Watching For Direct Crude Price Exposure
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
GlobeNewswire  ·  08-25
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Is California Resources (CRC) Cheap On Strong Q2 Results And New Production Guidance?
Simply Wall St.  ·  08-23
Is California Resources (CRC) Cheap On Strong Q2 Results And New Production Guidance?
Adagene to Participate in Three Upcoming Investor Conferences
GlobeNewswire  ·  08-20
Adagene to Participate in Three Upcoming Investor Conferences
Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Dow Jones  ·  08-13
Press Release: Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
California Resources EVP, Chief Commercial Officer Jay A. Bys Sells 11,907 Shares for $642,978
Reuters  ·  08-13
California Resources EVP, Chief Commercial Officer Jay A. Bys Sells 11,907 Shares for $642,978
Centuri Names Kelly Youngblood CFO, Replacing Gregory Izenstark
Reuters  ·  08-13
Centuri Names Kelly Youngblood CFO, Replacing Gregory Izenstark
Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results
Dow Jones  ·  08-13
Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results
California Resources Publishes Investor Presentation Highlighting Reserves Runway, California Supply-Demand Trends and Operational Execution
Reuters  ·  08-12
California Resources Publishes Investor Presentation Highlighting Reserves Runway, California Supply-Demand Trends and Operational Execution
UBS Adjusts Price Target on California Resources to $67 From $70, Maintains Buy Rating
MT Newswires Live  ·  08-12
UBS Adjusts Price Target on California Resources to $67 From $70, Maintains Buy Rating
California Resources Corporation : UBS Cuts Target Price to $67 from $70
THOMSON REUTERS  ·  08-12
California Resources Corporation : UBS Cuts Target Price to $67 from $70
California Resources Posts Transcript of Q2 2026 Earnings Call
Reuters  ·  08-12
California Resources Posts Transcript of Q2 2026 Earnings Call
Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Dow Jones  ·  08-12
Press Release: BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
California Resources Corporation : Barclays Cuts Target Price to $77 from $80
THOMSON REUTERS  ·  08-11
California Resources Corporation : Barclays Cuts Target Price to $77 from $80
California Resources price target lowered to $77 from $80 at Barclays
TIPRANKS  ·  08-11
California Resources price target lowered to $77 from $80 at Barclays

Introduction

Company Name.
California Resources
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
California Resources Corporation operates as an independent oil and natural gas exploration and production company in the United States. The company explores, produces, and markets crude oil, natural gas, and natural gas liquids for marketers, California refineries, and other purchasers that have access to transportation and storage facilities. It also engages in the generation and sale of electricity to the local utility and the grid. The company was incorporated in 2014 and is based in Long Beach, California.
Issue price:
--